Global Mycoplasma Pneumoniae Rapid Test Kits Market Growth 2025-2031

The global Mycoplasma Pneumoniae Rapid Test Kits market size is predicted to grow from US$ 897 million in 2025 to US$ 1483 million in 2031; it is expected to grow at a CAGR of 8.7% from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Mycoplasma pneumoniae is a common pathogen that causes primary atypical pneumonia and other respiratory infections. 11% of adult pharyngitis and 33% of pediatric pharyngitis are caused by MP, and 10% to 20% of acute bronchitis and 3% to 5% of bronchiolitis patients have positive serum MP. Severe mycoplasma pneumoniae can lead to death. Mycoplasma Pneumonia Rapid Test kits are highly sensitive and specific, and are used to differentiate and diagnose Mycoplasma pneumoniae infection, providing a etiological diagnosis basis for clinical medication.

United States market for Mycoplasma Pneumoniae Rapid Test Kits is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Mycoplasma Pneumoniae Rapid Test Kits is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Mycoplasma Pneumoniae Rapid Test Kits is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Mycoplasma Pneumoniae Rapid Test Kits players cover Thermo Scientific, GeneProof, SERION Diagnostics, MERIDIAN BIOSCIENCE, Atila BioSystems, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Mycoplasma Pneumoniae Rapid Test Kits Industry Forecast” looks at past sales and reviews total world Mycoplasma Pneumoniae Rapid Test Kits sales in 2024, providing a comprehensive analysis by region and market sector of projected Mycoplasma Pneumoniae Rapid Test Kits sales for 2025 through 2031. With Mycoplasma Pneumoniae Rapid Test Kits sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Mycoplasma Pneumoniae Rapid Test Kits industry.

This Insight Report provides a comprehensive analysis of the global Mycoplasma Pneumoniae Rapid Test Kits landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Mycoplasma Pneumoniae Rapid Test Kits portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Mycoplasma Pneumoniae Rapid Test Kits market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Mycoplasma Pneumoniae Rapid Test Kits and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Mycoplasma Pneumoniae Rapid Test Kits.

This report presents a comprehensive overview, market shares, and growth opportunities of Mycoplasma Pneumoniae Rapid Test Kits market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Colloidal Gold
ELISA
Fluorescent PCR
Others

Segmentation by Application:
Hospital
Clinic
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Thermo Scientific
GeneProof
SERION Diagnostics
MERIDIAN BIOSCIENCE
Atila BioSystems
Advanced Molecular Diagnostics
Sansure Biotech
Wuhan Easy Diagnosis Biomedicine
Shanghai Bojie Medical Technology
Jiangsu Mole BioScience
Qingdao Hightop Biotech Co.,Ltd.
Nanjing Vazyme Medical Technology
Innovita Biological Technology
Guangdong Hexin Health Technology
Coyote Bioscience
Beijing GeneDetective Medical Technology
Wuhan Zhongzhi Biotechnologies
Shanghai Rendu Biological Technology
Daan Gene
Bao Ruiyuan Biotech
Xiamen Amplly Biotechnology
ACON Laboratories
Shenzhen Yilifang Biotech
Shanghai ZJ Bio-Tech
Zhengzhou Antu Bio-Engineering
BioPerfectus
Core Technology
JOYSBIO
Haitian Lanbo Biotech
Chengdu Kanghua Biological Products
Beijing Bell Biotechnology
Bioneovan
Sanming Bofeng Biotechnology
Beijing North Institute of Biotechnology
Xiamen Wiz Biotech

Key Questions Addressed in this Report

What is the 10-year outlook for the global Mycoplasma Pneumoniae Rapid Test Kits market?

What factors are driving Mycoplasma Pneumoniae Rapid Test Kits market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Mycoplasma Pneumoniae Rapid Test Kits market opportunities vary by end market size?

How does Mycoplasma Pneumoniae Rapid Test Kits break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver. Show more